Spebrutinib | m-entrepreneurship.com

Product Name :
Spebrutinib

Search keywords :
Spebrutinib

drugId :
null

Target Vo:
Tyrosine-protein kinase BTK

Target Vo Short Name :
BTK

Moa_Name:
Tyrosine-protein kinase BTK inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Celgene Corp

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Lymphoma, B-Cell

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-Nrf2 (Ser40) Rabbit mAb Purity & Documentation
Lifastuzumab custom synthesis
SNAI1 Antibody: SNAI1 Antibody is an unconjugated, approximately 29 kDa, rabbit-derived, anti-SNAI1 polyclonal antibody. SNAI1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, and predicted: mouse, rat background without labeling.

Author: Betaine hydrochloride

Related Posts